EquityIndex FundsVery High Risk
Regular
NAV (03-Dec-24)
Returns (Since Inception)
Fund Size
₹121 Cr
Expense Ratio
1.11%
ISIN
INF277KA1BD0
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
26 Apr 2024
Equity | ₹121.29 Cr | 100.06% |
Others | ₹-0.08 Cr | -0.06% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹16.34 Cr | 13.48% |
Lupin Ltd | Equity | ₹11.4 Cr | 9.40% |
Aurobindo Pharma Ltd | Equity | ₹8.44 Cr | 6.97% |
Fortis Healthcare Ltd | Equity | ₹7.03 Cr | 5.80% |
Alkem Laboratories Ltd | Equity | ₹6.53 Cr | 5.39% |
Glenmark Pharmaceuticals Ltd | Equity | ₹5.52 Cr | 4.55% |
Mankind Pharma Ltd | Equity | ₹5.44 Cr | 4.49% |
Ipca Laboratories Ltd | Equity | ₹4.66 Cr | 3.85% |
Laurus Labs Ltd | Equity | ₹4.18 Cr | 3.45% |
Suven Pharmaceuticals Ltd | Equity | ₹3.6 Cr | 2.97% |
Piramal Pharma Ltd | Equity | ₹3.57 Cr | 2.95% |
Syngene International Ltd | Equity | ₹3.35 Cr | 2.77% |
Abbott India Ltd | Equity | ₹3.27 Cr | 2.70% |
Biocon Ltd | Equity | ₹3.07 Cr | 2.54% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹3.02 Cr | 2.49% |
Krishna Institute of Medical Sciences Ltd | Equity | ₹2.89 Cr | 2.38% |
Gland Pharma Ltd | Equity | ₹2.84 Cr | 2.34% |
Ajanta Pharma Ltd | Equity | ₹2.79 Cr | 2.30% |
Natco Pharma Ltd | Equity | ₹2.75 Cr | 2.27% |
Dr. Lal PathLabs Ltd | Equity | ₹2.48 Cr | 2.04% |
GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹2.43 Cr | 2.00% |
Poly Medicure Ltd | Equity | ₹2.36 Cr | 1.95% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹2.05 Cr | 1.69% |
Global Health Ltd | Equity | ₹1.99 Cr | 1.64% |
Narayana Hrudayalaya Ltd | Equity | ₹1.87 Cr | 1.54% |
Granules India Ltd | Equity | ₹1.78 Cr | 1.47% |
Rainbow Childrens Medicare Ltd | Equity | ₹1.74 Cr | 1.43% |
Alembic Pharmaceuticals Ltd | Equity | ₹1.37 Cr | 1.13% |
Sanofi India Ltd | Equity | ₹1.34 Cr | 1.10% |
Metropolis Healthcare Ltd | Equity | ₹1.2 Cr | 0.99% |
Net Current Liabilities | Cash - Collateral | ₹-0.14 Cr | 0.12% |
A) Repo | Cash - Repurchase Agreement | ₹0.06 Cr | 0.05% |
Large Cap Stocks
4.49%
Mid Cap Stocks
65.72%
Small Cap Stocks
29.86%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹121.29 Cr | 100.06% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since April 2024
ISIN INF277KA1BD0 | Expense Ratio 1.11% | Exit Load No Charges | Fund Size ₹121 Cr | Age 7 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty MidSmall Healthcare Index (TRI) |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
ICICI Prudential Nifty Midcap 150 Index Fund Direct Growth Very High Risk | 0.3% | 0.0% | ₹565.80 Cr | - |
ICICI Prudential Nifty Midcap 150 Index Fund Regular Growth Very High Risk | 0.9% | 0.0% | ₹565.80 Cr | - |
ICICI Prudential Nifty 200 Momentum 30 Index Fund Regular Growth Very High Risk | 1.0% | 0.0% | ₹471.41 Cr | - |
SBI Nifty Midcap 150 Index Fund Regular Growth Very High Risk | 1.0% | 0.0% | ₹670.31 Cr | - |
DSP Nifty 50 Equal Weight Index Fund Regular Growth Very High Risk | 0.9% | 0.0% | ₹1886.93 Cr | - |
SBI Nifty Smallcap 250 Index Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹1190.98 Cr | - |
SBI Nifty Midcap 150 Index Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹670.31 Cr | - |
ICICI Prudential Nifty 200 Momentum 30 Index Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹471.41 Cr | - |
DSP Nifty 50 Equal Weight Index Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹1886.93 Cr | - |
SBI Nifty Smallcap 250 Index Fund Regular Growth Very High Risk | 1.0% | 0.0% | ₹1190.98 Cr | - |
Your principal amount will be at Very High Risk